Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Literature DB >> 29466761

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Ariella Glasner, Assi Levi, Jonatan Enk, Batya Isaacson, Sergey Viukov, Shari Orlanski, Alon Scope, Tzahi Neuman, Claes D Enk, Jacob H Hanna, Veronika Sexl, Stipan Jonjic, Barbara Seliger, Laurence Zitvogel, Ofer Mandelboim.

Abstract

Entities: Gene

Year: 2018 PMID： 29466761 PMCID： PMC5823842 DOI： 10.1016/j.immuni.2018.01.010

Source DB: PubMed Journal: Immunity ISSN： 1074-7613 Impact factor: 31.745

× No keyword cloud information.

(Immunity 48, 107–119; January 16, 2018) In the version of this article originally published online on January 9, Figure 3 was printed twice, once correctly and once wrongly in place of Figure 4. The paper has been corrected online. The authors regret the error and the publisher apologies for the oversight. The correct Figure 4 appears here. (Corrected) (Original)

16 in total

Review 1. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors: Lionel B Ivashkiv
Journal: Nat Rev Immunol Date: 2018-09 Impact factor: 53.106

2. Circulating NKp46⁺ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Authors: Emilie Picard; Yann Godet; Caroline Laheurte; Magalie Dosset; Jeanne Galaine; Laurent Beziaud; Romain Loyon; Laura Boullerot; Elodie Lauret Marie Joseph; Laurie Spehner; Marion Jacquin; Guillaume Eberst; Béatrice Gaugler; Françoise Le Pimpec-Barthes; Elizabeth Fabre; Virginie Westeel; Anne Caignard; Christophe Borg; Olivier Adotévi
Journal: Oncoimmunology Date: 2018-10-19 Impact factor: 8.110

10. A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment.

Authors: A Farias; A Soto; F Puttur; C J Goldin; S Sosa; C Gil; F A Goldbaum; P M Berguer
Journal: Sci Rep Date: 2021-07-28 Impact factor: 4.379

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Review 1. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

2. Circulating NKp46⁺ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Review 3. The Tumor Microenvironment Innately Modulates Cancer Progression.

4. Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions.

Review 5. NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.

6. A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells.

7. Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity.

Review 8. The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy.

9. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme.

10. A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment.

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Review 1. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

2. Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Review 3. The Tumor Microenvironment Innately Modulates Cancer Progression.

4. Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions.

Review 5. NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.

6. A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells.

7. Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity.

Review 8. The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy.

9. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme.

10. A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment.

2. Circulating NKp46⁺ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.